Pfizer Limited (BOM: 500680)

India flag India · Delayed Price · Currency is INR
4,929.95
-26.55 (-0.54%)
At close: Jan 20, 2025
15.28%
Market Cap 225.72B
Revenue (ttm) 22.38B
Net Income (ttm) 6.18B
Shares Out n/a
EPS (ttm) 135.06
PE Ratio 36.53
Forward PE n/a
Dividend 35.00 (0.71%)
Ex-Dividend Date Aug 21, 2024
Volume 889
Average Volume 2,192
Open 4,956.50
Previous Close 4,956.50
Day's Range 4,911.55 - 4,969.90
52-Week Range 4,050.10 - 6,452.85
Beta n/a
RSI 40.19
Earnings Date Feb 14, 2025

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare... [Read more]

Industry Pharmaceutical Preparations
Founded 1950
Employees 1,721
Stock Exchange Bombay Stock Exchange
Ticker Symbol 500680
Full Company Profile

Financial Performance

In 2023, Pfizer's revenue was 21.93 billion, a decrease of -9.55% compared to the previous year's 24.25 billion. Earnings were 5.51 billion, a decrease of -11.64%.

Financial Statements

News

There is no news available yet.